Literature DB >> 31102184

Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure.

Adam R Denton1, Srimal A Samaranayake2, Kristin N Kirchner1, Robert F Roscoe1, Shane N Berger2, Steven B Harrod1, Charles F Mactutus1, Parastoo Hashemi2, Rosemarie M Booze3.   

Abstract

Between 30 and 60% of HIV-seropositive individuals develop symptoms of clinical depression and/or apathy. Dopamine and serotonin are associated with motivational alterations; however, histamine is less well studied. In the present study, we used fast-scan cyclic voltammetry in HIV-1 transgenic (Tg) rats to simultaneously analyze the kinetics of nucleus accumbens dopamine (DA), prefrontal cortical serotonin (5-HT), and hypothalamic histamine (HA). For voltammetry, subjects were 15 HIV-1 Tg (7 male, 8 female) and 20 F344/N (11 male, 9 female) adult rats. Both serotonergic and dopaminergic release and reuptake kinetics were decreased in HIV-1 Tg animals relative to controls. In contrast, rates of histamine release and reuptake increased in HIV-1 Tg rats. Additionally, we used immunohistochemical (IHC) methods to identify histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus. For IHC, subjects were 9 HIV-1 Tg (5 male, 4 female) and 9 F344/N (5 male, 4 female) adult rats. Although the total number of TMN histaminergic cells did not differ between HIV-1 Tg rats and F344/N controls, a significant sex effect was found, with females having an increased number of histaminergic neurons, relative to males. Collectively, these findings illustrate neurochemical alterations that potentially underlie or exacerbate the pathogenesis of clinical depression and/or apathy in HIV-1.

Entities:  

Keywords:  Dopamine; Fast-scan cyclic voltammetry; HIV-1; Histamine immunohistochemistry; Nucleus accumbens; Serotonin

Year:  2019        PMID: 31102184      PMCID: PMC6750960          DOI: 10.1007/s13365-019-00754-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  62 in total

Review 1.  The role of histamine and the tuberomamillary nucleus in the nervous system.

Authors:  Helmut Haas; Pertti Panula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

2.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

Review 3.  Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

Authors:  A Nath; C Anderson; M Jones; W Maragos; R Booze; C Mactutus; J Bell; K F Hauser; M Mattson
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

4.  Estrous cyclicity and behavioral sensitization in female rats following repeated intravenous cocaine administration.

Authors:  R M Booze; M L Wood; M A Welch; S Berry; C F Mactutus
Journal:  Pharmacol Biochem Behav       Date:  1999-11       Impact factor: 3.533

Review 5.  The physiology of brain histamine.

Authors:  R E Brown; D R Stevens; H L Haas
Journal:  Prog Neurobiol       Date:  2001-04       Impact factor: 11.685

6.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2004-10-27       Impact factor: 6.167

8.  Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.

Authors:  P J Fletcher; Z F Selhi; A Azampanah; T L Sills
Journal:  Neuropsychopharmacology       Date:  2001-04       Impact factor: 7.853

Review 9.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

10.  Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.

Authors:  Sarah Threlfell; Stephanie J Cragg; Imre Kalló; Gergely F Turi; Clive W Coen; Susan A Greenfield
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

View more
  9 in total

Review 1.  An Empirical Mediation Analysis of Mechanisms Underlying HIV-1-Associated Neurocognitive Disorders.

Authors:  Kristen A McLaurin; Charles F Mactutus; Rosemarie M Booze; Amanda J Fairchild
Journal:  Brain Res       Date:  2019-09-09       Impact factor: 3.252

Review 2.  HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.

Authors:  Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Kristen A McLaurin; Asha Kallianpur; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-12       Impact factor: 4.147

3.  A Hydrophobic Tissue Clearing Method for Rat Brain Tissue.

Authors:  Kristin N Kirchner; Hailong Li; Adam R Denton; Steven B Harrod; Charles F Mactutus; Rosemarie M Booze
Journal:  J Vis Exp       Date:  2020-12-23       Impact factor: 1.355

4.  Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.

Authors:  Adam R Denton; Charles F Mactutus; Almeera U Lateef; Steven B Harrod; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2021-05-18       Impact factor: 3.739

5.  Deprenyl reduces inflammation during acute SIV infection.

Authors:  K M Emanuel; K Runner; Z D Brodnik; B M Morsey; B G Lamberty; H S Johnson; A Acharya; S N Byrareddy; R A España; H S Fox; P J Gaskill
Journal:  iScience       Date:  2022-04-06

6.  S-Equol mitigates motivational deficits and dysregulation associated with HIV-1.

Authors:  Kristen A McLaurin; Sarah J Bertrand; Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Rosemarie M Booze
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

7.  Neurodevelopmental Processes in the Prefrontal Cortex Derailed by Chronic HIV-1 Viral Protein Exposure.

Authors:  Kristen A McLaurin; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

8.  Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats.

Authors:  Kristen A McLaurin; Hailong Li; Charles F Mactutus; Steven B Harrod; Rosemarie M Booze
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

9.  Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders.

Authors:  Hailong Li; Kristen A McLaurin; Jessica M Illenberger; Charles F Mactutus; Rosemarie M Booze
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.